DarioHealth Corp. Files 8-K on Shareholder Votes
Ticker: DRIO · Form: 8-K · Filed: Dec 18, 2024 · CIK: 1533998
| Field | Detail |
|---|---|
| Company | Dariohealth CORP. (DRIO) |
| Form Type | 8-K |
| Filed Date | Dec 18, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
TL;DR
DarioHealth Corp. filed an 8-K for shareholder votes on Dec 18, 2024.
AI Summary
DarioHealth Corp. filed an 8-K on December 18, 2024, to report on matters submitted to a vote of its security holders. The filing does not contain specific details about the votes or resolutions presented, but it formally documents that such a submission occurred on or before December 18, 2024.
Why It Matters
This filing indicates that DarioHealth Corp. has held or is holding a shareholder vote, which could pertain to significant corporate actions like board elections or major strategic decisions.
Risk Assessment
Risk Level: low — The filing is procedural and does not disclose any new financial or operational risks.
Key Players & Entities
- DarioHealth Corp. (company) — Registrant
- December 18, 2024 (date) — Date of Report
FAQ
What specific matters were submitted to a vote of DarioHealth Corp. security holders?
The provided filing excerpt does not specify the exact matters submitted for a vote, only that a submission occurred.
When was the earliest event reported in this 8-K filing?
The earliest event reported is December 18, 2024.
What is DarioHealth Corp.'s principal executive office address?
The principal executive offices are located at 122 W 57th St, #33B, New York, New York 10019.
What was DarioHealth Corp.'s former company name?
The former company name was LabStyle Innovations Corp.
What is the Commission File Number for DarioHealth Corp.?
The Commission File Number is 001-37704.
Filing Stats: 583 words · 2 min read · ~2 pages · Grade level 11.8 · Accepted 2024-12-18 16:05:20
Key Financial Figures
- $0.0001 — registered Common Stock, par value $0.0001 per share DRIO The Nasdaq Capital M
Filing Documents
- tm2431479d1_8k.htm (8-K) — 37KB
- 0001104659-24-129752.txt ( ) — 206KB
- drio-20241218.xsd (EX-101.SCH) — 3KB
- drio-20241218_lab.xml (EX-101.LAB) — 33KB
- drio-20241218_pre.xml (EX-101.PRE) — 22KB
- tm2431479d1_8k_htm.xml (XML) — 4KB
07
Item 5.07 Submission of Matters to a Vote of Security Holders. On December 18, 2024, DarioHealth Corp. (the " Company ") held its 2024 Annual Meeting of Stockholders (the " 2024 Annual Meeting "). The final voting results of the 2024 Annual Meeting are set forth below. Stockholders voted on the following proposals: Proposal No. 1 — Election of Directors. The stockholders elected the following directors of the Company to hold office until the next annual meeting of stockholders and until their respective successors shall be elected and qualified or until their earlier resignation or removal. The votes were as follows (including shares of preferred stock eligible to vote, on an as converted basis): Director Name For Against Abstain Broker Non-Votes Hila Karah 15,939,360 127,477 35,224 6,671,020 Dennis Matheis 15,823,755 243,082 35,224 6,671,020 Dennis M. McGrath 15,864,338 201,911 35,812 6,671,020 Erez Raphael 15,936,730 129,564 35,767 6,671,020 Yoav Shaked 15,861,165 205,129 35,767 6,671,020 Jon Kaplan 15,871,746 195,090 35,225 6,671,020 Adam K. Stern 15,913,677 143,403 44,981 6,671,020 Proposal No. 2 — Ratification of Auditors. The stockholders ratified the appointment of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2024. The votes were as follows (including shares of preferred stock eligible to vote, on an as converted basis): For Against Abstain 22,649,674 106,250 17,517
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: December 18, 2024 DARIOHEALTH CORP. By: /s/ Zvi Ben David Name: Zvi Ben David Title: Chief Financial Officer, Treasurer and Secretary